Semaglutide is a GLP-1 receptor agonist that mimics a hormone your gut naturally produces to regulate blood sugar and appetite
J Muscle Res Cell Motil
You can maintain results after treatment by making intentional changes before, during, and after stopping the medication
In 2019, it approved a different formulation of semaglutide, Rybelsus, for reducing blood sugar levels in adults with type 2 diabetes
In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)
Together, these peptides are applied in research environments to examine multi-compound systems, peptide interactions, and pathway relationships under controlled conditions